Economic evaluation of biosimilars for reimbursement purposes - what, when, how?
Economic evaluation of biosimilars for reimbursement purposes - what, when, how? (Taylor & Francis).
Arzneimittel - Assessment - Biologika - Biosimilars - Health-Technology-Assessment HTA - Kalkulation - Pharmaindustrie - Reimbursement - Zusatzentgelt - URL